Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-30 @ 4:15 PM
Study NCT ID:
NCT04577404
Status:
COMPLETED
Last Update Posted:
2025-09-08
First Post:
2020-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Sponsor:
Tanabe Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-30
First Submit QC Date:
None
Study First Post Date:
2020-10-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-29
Results First Submit QC Date:
None
Results First Post Date:
2024-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-26
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED